A Translational Model for Hypertrophic Cardiomyopathy in Cats


Overview and Advantages
Hypertrophic cardiomyopathy (HCM) is the most common primary cardiac disorder in cats, particularly prevalent in genetically predisposed breeds such as Maine Coons and Ragdolls. Severe cases can lead to heart failure, thromboembolism, or sudden cardiac death.
YiJi Biology has developed a standardized feline HCM model that successfully replicates key pathological features of the disease, including left ventricular wall thickening, atrial enlargement, and impaired cardiac function. Our model, established through selective breeding and functional induction protocols, offers high stability, clear disease staging, and strong reproducibility—making it a valuable tool for both veterinary cardiology drug development and translational human cardiovascular research.
High Pathological Fidelity
Recapitulates hallmark HCM features such as myocardial hypertrophy, left atrial enlargement, and hemodynamic alterations.
Internationally Aligned Standards
Capable of consistently inducing systolic anterior motion (SAM) and left ventricular outflow tract obstruction (LVOTO), key endpoints in clinical research.
Clear Disease Staging & Standardized Data Structure
Supports intervention studies at multiple disease stages with high data consistency.
Dual Utility for Veterinary and Human Drug Development
Enables cross-species translational studies in cardiovascular medicine.
Well-Validated & Highly Reproducible
Supported by robust datasets from multiple model animals across longitudinal studies.
Key Echocardiography Data under Dobutamine Challenge

01
Dobutamine Stress Echocardiography (M-Mode) in Model Cats
(Data from YiJi Biology)
02
Dobutamine Stress Echocardiography (Doppler Mode) in Model Cats
(Data from YiJi Biology)


03
Dobutamine challenge significantly increases LVOT PGmax and reduces LVESD in model cats
(Data from YiJi Biology)
CRO Support & Custom Services
We offer fully integrated preclinical research services based on the HCM model, including:
High-resolution echocardiography (M-Mode and Doppler) image acquisition and analysis.
Design and execution of dobutamine stress testing protocols.
Animal selection and staging for longitudinal studies.
Behavioral and physiological monitoring of model animals.
Comprehensive pharmacodynamic data analysis and regulatory reporting support.
Interested in this model or need a customized study?
Contact Us to discuss your research goals.
